• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥马珠单抗和抗抑郁药治疗后性疾病综合征:一例报告

Postorgasmic illness syndrome benefiting from omalizumab and antidepressant: a case report.

作者信息

Okan Kasım, Kural Ragıp Fatih, Demir Meryem, Cot Furkan, Dinckal Mustafa, Altay Sevgi, Gökmen Nihal Mete

机构信息

Department of Internal Medicine, Division of Allergy and Immunology, Ege University, Izmir, Turkey.

Department of Urology, Ege University, Izmir, Turkey.

出版信息

J Med Case Rep. 2024 Dec 21;18(1):632. doi: 10.1186/s13256-024-04986-2.

DOI:10.1186/s13256-024-04986-2
PMID:39707470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11662807/
Abstract

BACKGROUND

Postorgasmic illness syndrome is characterized by flu, rhinitis, conjunctivitis, loss of appetite, muscle weakness, and fatigue after ejaculation, lasting 2-7 days. The multidisciplinary treatment approach, incorporating omalizumab and antidepressants, has rarely been documented in literature.

CASE PRESENTATION

In this article, we present the case of a 33-year-old single Turkish male with postorgasmic illness syndrome, characterized by typical clinical symptoms and a positive autologous semen test. Notably, his serum estrogen and progesterone levels were elevated. The patient's Beck anxiety score was 42 points, the depression scale score was 37, and suicidal thoughts. Fresh autologous semen taken at the hospital was diluted with 0.9% saline, and prick and intradermal skin tests were performed.

CONCLUSION

The patient's symptoms improved significantly with the combination of omalizumab and escitalopram. This case not only provides a new perspective on the management of postorgasmic illness syndrome but also highlights the potential roles of allergic, psychiatric, and endocrinological mechanisms in the etiology and treatment of this complex condition.

摘要

背景

性高潮后疾病综合征的特征为射精后出现流感样症状、鼻炎、结膜炎、食欲不振、肌肉无力和疲劳,持续2至7天。文献中很少有关于将奥马珠单抗和抗抑郁药纳入多学科治疗方法的记载。

病例介绍

在本文中,我们介绍了一名33岁的单身土耳其男性患性高潮后疾病综合征的病例,其具有典型的临床症状且自体精液检测呈阳性。值得注意的是,他的血清雌激素和孕酮水平升高。患者的贝克焦虑评分为42分,抑郁量表评分为37分,并有自杀念头。在医院采集的新鲜自体精液用0.9%生理盐水稀释后,进行了点刺和皮内皮肤试验。

结论

奥马珠单抗和艾司西酞普兰联合使用后,患者症状显著改善。该病例不仅为性高潮后疾病综合征的管理提供了新视角,还突出了过敏、精神和内分泌机制在这一复杂病症的病因和治疗中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee0/11662807/210bc32bcea2/13256_2024_4986_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee0/11662807/4847f127e78c/13256_2024_4986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee0/11662807/210bc32bcea2/13256_2024_4986_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee0/11662807/4847f127e78c/13256_2024_4986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee0/11662807/210bc32bcea2/13256_2024_4986_Fig2_HTML.jpg

相似文献

1
Postorgasmic illness syndrome benefiting from omalizumab and antidepressant: a case report.奥马珠单抗和抗抑郁药治疗后性疾病综合征:一例报告
J Med Case Rep. 2024 Dec 21;18(1):632. doi: 10.1186/s13256-024-04986-2.
2
A Role for IgE in Post-Orgasmic Illness Syndrome: Successful Omalizumab Treatment in Absence of Positive Skin Test to Self Semen.IgE在性高潮后疾病综合征中的作用:在对自身精液皮肤试验阴性的情况下,奥马珠单抗治疗成功
Am J Case Rep. 2025 Feb 2;26:e945529. doi: 10.12659/AJCR.945529.
3
Postorgasmic illness syndrome (POIS) in a Chinese man: no proof for IgE-mediated allergy to semen.一名中国男性的性高潮后疾病综合征(POIS):无IgE介导的精液过敏证据
J Sex Med. 2015 Mar;12(3):840-5. doi: 10.1111/jsm.12813. Epub 2015 Jan 29.
4
Negative allergy study in a case of postorgasmic illness syndrome (POIS).一例性高潮后疾病综合征(POIS)患者的过敏阴性研究。
Rev Int Androl. 2018 Jan-Mar;16(1):42-44. doi: 10.1016/j.androl.2017.06.002. Epub 2017 Oct 10.
5
Postorgasmic Illness Syndrome (POIS) in 45 Dutch caucasian males: clinical characteristics and evidence for an immunogenic pathogenesis (Part 1).45 名荷兰白种男性中的 postorgasmic illness syndrome (POIS):临床特征和免疫发病机制的证据(第 1 部分)。
J Sex Med. 2011 Apr;8(4):1164-70. doi: 10.1111/j.1743-6109.2010.02166.x. Epub 2011 Jan 17.
6
Clinical characteristics, allergic response to autologous semen, and desensitization in patients with postorgasmic illness syndrome.性高潮后疾病综合征患者的临床特征、对自身精液的过敏反应及脱敏治疗
Sex Med. 2024 Jan 17;11(6):qfad068. doi: 10.1093/sexmed/qfad068. eCollection 2023 Dec.
7
Post-orgasmic illness syndrome with positive intradermal test for autologous semen.自身精液皮内试验阳性的性高潮后疾病综合征。
J Dermatol. 2023 Jul;50(7):951-955. doi: 10.1111/1346-8138.16762. Epub 2023 Mar 7.
8
Post-Orgasmic Illness Syndrome Successfully Treated with Omalizumab: A Case Report.奥马珠单抗治疗性高潮后疾病综合征 1 例报告。
J Sex Marital Ther. 2024;50(3):342-345. doi: 10.1080/0092623X.2023.2295256. Epub 2023 Dec 21.
9
Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).自体精液脱敏疗法治疗两名荷兰白种男性:在后射精期疾病综合征(POIS;第 2 部分)中的有益效果。
J Sex Med. 2011 Apr;8(4):1171-6. doi: 10.1111/j.1743-6109.2010.02167.x. Epub 2011 Jan 17.
10
Solar urticaria induced by visible light: successful treatment with omalizumab.可见光诱发的日光性荨麻疹:奥马珠单抗治疗成功
Clin Exp Dermatol. 2016 Dec;41(8):890-892. doi: 10.1111/ced.12951. Epub 2016 Oct 20.

本文引用的文献

1
Post orgasmic illness syndrome: a review.性高潮后疾病综合征:综述
Int J Impot Res. 2024 Mar 14. doi: 10.1038/s41443-024-00860-3.
2
Post-Orgasmic Illness Syndrome Successfully Treated with Omalizumab: A Case Report.奥马珠单抗治疗性高潮后疾病综合征 1 例报告。
J Sex Marital Ther. 2024;50(3):342-345. doi: 10.1080/0092623X.2023.2295256. Epub 2023 Dec 21.
3
Case series: expanding diagnostic markers in postorgasmic illness syndrome.病例系列:后性高潮疾病综合征中不断扩展的诊断标志物
Sex Med. 2023 Mar 2;11(2):qfac021. doi: 10.1093/sexmed/qfac021. eCollection 2023 Apr.
4
A Case Report of Postcoital Dysphoria: A Paradoxical Melancholy.性交后烦躁症病例报告:一种矛盾的忧郁症
Cureus. 2022 Oct 27;14(10):e30746. doi: 10.7759/cureus.30746. eCollection 2022 Oct.
5
Post orgasmic illness syndrome successfully managed with antihistamine: A case report.用抗组胺药成功治疗性高潮后疾病综合征:一例报告
Urol Case Rep. 2022 Aug 18;45:102189. doi: 10.1016/j.eucr.2022.102189. eCollection 2022 Nov.
6
Novel treatment for post-orgasmic illness syndrome: a case report and literature review.性高潮后疾病综合征的新型治疗方法:一例病例报告及文献综述
Asian J Androl. 2022 May-Jun;24(3):332-334. doi: 10.4103/aja202170.
7
Analysis of the Symptomatology, Disease Course, and Treatment of Postorgasmic Illness Syndrome in a Large Sample.大样本中与性高潮后疾病相关的症状、病程和治疗的分析。
J Sex Med. 2020 Nov;17(11):2229-2235. doi: 10.1016/j.jsxm.2020.08.020. Epub 2020 Sep 30.
8
Clinical experience with post-orgasmic illness syndrome (POIS) patients-characteristics and possible treatment modality.与性高潮后疾病综合征 (POIS) 患者相关的临床经验——特征和可能的治疗方式。
Int J Impot Res. 2021 Jul;33(5):556-562. doi: 10.1038/s41443-020-0314-9. Epub 2020 May 29.
9
Successful treatment of Post-orgasmic illness syndrome with human chorionic gonadotropin.用人绒毛膜促性腺激素成功治疗性高潮后疾病综合征。
Urol Case Rep. 2019 Nov 22;29:101078. doi: 10.1016/j.eucr.2019.101078. eCollection 2020 Mar.
10
Negative allergy study in a case of postorgasmic illness syndrome (POIS).一例性高潮后疾病综合征(POIS)患者的过敏阴性研究。
Rev Int Androl. 2018 Jan-Mar;16(1):42-44. doi: 10.1016/j.androl.2017.06.002. Epub 2017 Oct 10.